Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai

AIDS Research and Human Retroviruses

Volumn 23, Issue 7, 2007, Pages 847-856

  Zhong, Ping ^a   Pan, Qichao ^a   Ning, Zhen ^a   Xue, Yile ^a   Gong, Juli ^a   Zhen, Xiaohong ^a   Zhou, Leiming ^a   Sheng, Fangwei ^a   Zhang, Wei ^a   Gai, Jing ^a   Cheng, Hua ^a   Yue, Qing ^a   Xing, Hui ^a   Zhuang, Minghua ^a   Lu, Wei ^a   Shao, Yiming ^a   Kang, Laiyi ^a,b  

^a SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CHINA; EPIDEMIC; FEMALE; GENE AMPLIFICATION; GENETIC VARIABILITY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; STRUCTURAL GENE; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; DRUG RESISTANCE, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENES, POL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; PROTEASE INHIBITORS; VARIATION (GENETICS);

EID: 34547944782     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0196     Document Type: Article

References (30)

1. China Ministry of Public Health: News Press, Report on the progress of HIV/AIDS prevention and control in China 2005. Available at http://www.moh.gov. cn. Last accessed 05/25/2006 (in Chinese).
2. Ministry of Public Health, People's Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization: 2005 Update on the HIV/AIDS Epidemic and Response in China, 24 January 2006.
3. Shao YM, Su L, Sun XH, et al.: Molecular epidemiology of HIV infection in China. XII International Conference on AIDS, June 28-July 3, 1998, Geneva. 12:111-112 (abstract no. 13132).
4. Shao Y: AIDS in south and southeast Asia. HIV/AIDS: Perspective on China. AIDS Patient Care STDs 2001;15:431-432.
5. Ministry of Science and Technology, China: Research progress: Nationwide HIV molecular epidemiology survey and its database setting (May 30, 2004). Available at http://shgy.jhgl.org/shownews.asp?nevvsid=893. Last accessed 05/25/2006 (in Chinese).
6. Han XX, Zhang M, Cui WG, et al.: Efficacy of anti-HIV treatment and drug-resistance mutations in some parts of China. Zhonghua Yi Xue Za Zhi 2005;85:760-764 (in Chinese).
7. Li JY, Li HP, Li L, et al.: Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res 2005;15:843-849.
8. Yang K, Li JY, Bao ZY, et al.: Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naive AIDS patients in Henan province. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26:351-355 (in Chinese).
9. Korber BT, Osmanov S, Esparza J, et al.: The WHO for HIV Isolation and Characterization. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. AIDS Res Hum Retroviruses 1994;11:1355-1358.
10. Available at http://www.hiv.lanl.gov/content/hiv-db/mainpage.html.
11. Thompson JD, Gibson TJ, Plewniak F, et al.: The CLUSTAL X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25: 4876-4882.
12. A multiple sequence alignment editor, Laboratory for Interdisciplinary Technologies in Bioinformatics, Italy: Available at http://portal.litbio.org/ Registered/Option/seaview.html.
13. Kumar S, Tamura K, Nei M: MEGA3: Integrated Software for Molecular Evolutionary Genetics Analysis and Sequence Alignment. Brief Bioinform 2004;5:150-163.
14. Los Alamos National Laboratory: USA HIV Sequence Database. Available at http://hiv-web.lanl.gov/content/hiv-db/BASIC_BLAST/basic_blast.html.
15. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160.
16. Stanford University HIV Drug Resistance Dalabase. Available at http://hivdb.stanford.edu/.
17. Zhong P, Kang L, Pan Q, et al.: Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P.R. China. J Acquir Immune Defic Syndr 2003;34:91-101.
18. Nyambi P, Heyndrickx L, Vereecken K, et al.: Predominance of infection wilh HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. AIDS 2002;16:295-296.
19. Zhong P, Burda S, Konings F, et al.: Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: Further evidence of broad HIV type 1 genelic diversity. AIDS Res Hum Retroviruses 2003; 19:1167-1178.
20. Konings FA, Zhong P, Agwara M, et al.: Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon. AIDS Res Hum Retroviruses 2004;20:105-109.
21. Tovanabutra S, Polonis V, De Souza M, et al.: First CRF01_AE/B recombinant of HIV-1 found in Thailand. AIDS 2001;15:1063-1065.
22. Ramos A, Nguyen L, Hu DJ, et al.: New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand. AIDS Res Hum Retroviruses 2003;19:667-674.
23. Tee KK, Pon CK, Kamarulzaman A, et al.: Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS 2005;19:119-126.
24. Tovanabutra S, Watanaveeradej V, Viputtikul K, et al.: A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res Hum Retroviruses 2003;19:561-567.
25. Wensing AMJ and Boucher CAB: Worldwide transmission of drug-resistant HIV. AIDS Rev 2003;5:140-155.
26. Weinstock HS, Zaidi I, Heneine W, et al.: The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis 2004;189:2174-2180.
27. Wensing AMJ, van de Vijver DAMC, Asjo B, et al.: Analysis from more than 1600 newly diagnosed patients with HIV from 17 European countries show that 10% of ihe patients carry primary drug resistance: The CATCH study. Second International AIDS Society Conference on HIV Pathogenesis and Treatment, Paris, July 13-16, 2003.
28. Oette M, Kaiser R, Daumer M, et al.: Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr 2006;41:573-581.
29. Van Vaerenbergh K, Debaisieux L, De Cabooler N, et al.: Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium. Antiviral Ther 2001;6:63-70.
30. Markowitz M, Mohri H, Mehandru S, et al.: Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: A case report. Lancet 2005;365:1031-1038.